Creatinine variation improves Zwolle score in selecting low-risk patients after ST-segment elevation myocardial infarction

医学 内科学 心肌梗塞 经皮冠状动脉介入治疗 临床终点 传统PCI 肌酐 弗雷明翰风险评分 心脏病学 疾病 临床试验
作者
D Bras,António Gomes,Pedro Semedo,Ana Rita Santos,B Picarra,M Carrington,João Pais,Ana Rita Rocha,K Congo,David Neves,Ângela Bento,Renato Fernandes,M Trinca,Lino Patrício
出处
期刊:Coronary Artery Disease [Lippincott Williams & Wilkins]
卷期号:32 (6): 489-499 被引量:1
标识
DOI:10.1097/mca.0000000000001002
摘要

The Zwolle score is recommended to identify ST-segment elevation myocardial infarction (STEMI) patients with low-risk eligible for early discharge. Our aim was to ascertain if creatinine variation (Δ-sCr) would improve Zwolle score in the decision-making of early discharge after primary percutaneous coronary intervention (PCI).A total of 3296 patients with STEMI that underwent primary PCI were gathered from the Portuguese Registry on Acute Coronary Syndromes. A Modified-Zwolle score, including Δ-sCr, was created and compared with the original Zwolle score. Δ-sCr was also compared between low (Zwolle score ≤3) and non-low-risk patients (Zwolle score >3). The primary endpoint is 30-day mortality and the secondary endpoints are in-hospital mortality and complications. Thirty-day mortality was 1.5% in low-risk patients (35 patients) and 9.2% in non-low-risk patients (92 patients). The Modified-Zwolle score had a better performance than the original Zwolle score in all endpoints: 30-day mortality (area under curve 0.853 versus 0.810, P < 0.001), in-hospital mortality (0.889 versus 0.845, P < 0.001) and complications (0.728 versus 0.719, P = 0.037). Reclassification of patients lead to a net reclassification improvement of 6.8%. Additionally, both original Zwolle score low-risk patients and non-low-risk patients who had a Δ-sCr ≥0.3 mg/dl had higher 30-day mortality (low-risk: 1% versus 6.6%, P < 0.001; non-low-risk 4.4% versus 20.7%, P < 0.001), in-hospital mortality and complications.Δ-sCr enhanced the performance of Zwolle score and was associated with higher 30-day mortality, in-hospital mortality and complications in low and non-low-risk patients. This data may assist the selection of low-risk patients who will safely benefit from early discharge after STEMI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
雪途完成签到,获得积分10
刚刚
在水一方应助小姜采纳,获得10
刚刚
kevin完成签到,获得积分10
1秒前
2秒前
FengGo完成签到,获得积分10
2秒前
2秒前
2秒前
哈基米德应助悟空采纳,获得20
3秒前
lslfreedom发布了新的文献求助10
3秒前
Panchael完成签到,获得积分10
3秒前
Lu完成签到,获得积分10
3秒前
哈先森完成签到,获得积分10
4秒前
4秒前
1410发布了新的文献求助10
4秒前
专注白安发布了新的文献求助10
4秒前
陈思完成签到,获得积分10
4秒前
5秒前
陈住气关注了科研通微信公众号
5秒前
badyoungboy完成签到,获得积分10
5秒前
美满的冬卉完成签到 ,获得积分10
6秒前
6秒前
7秒前
8秒前
呃呃呃呃呃完成签到 ,获得积分10
8秒前
赵伟完成签到,获得积分10
8秒前
ST完成签到 ,获得积分10
8秒前
FCZ完成签到,获得积分10
8秒前
8秒前
交个朋友完成签到 ,获得积分10
9秒前
wangdqi发布了新的文献求助10
9秒前
9秒前
邵星宇完成签到,获得积分10
9秒前
忘的澜完成签到,获得积分10
9秒前
leileiD完成签到,获得积分10
10秒前
10秒前
SYLH应助serier采纳,获得20
10秒前
10秒前
852应助lslfreedom采纳,获得10
10秒前
朴实夏旋完成签到,获得积分20
11秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
A new approach to the extrapolation of accelerated life test data 1000
徐淮辽南地区新元古代叠层石及生物地层 500
Coking simulation aids on-stream time 450
康复物理因子治疗 400
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4016278
求助须知:如何正确求助?哪些是违规求助? 3556388
关于积分的说明 11320934
捐赠科研通 3289218
什么是DOI,文献DOI怎么找? 1812421
邀请新用户注册赠送积分活动 887940
科研通“疑难数据库(出版商)”最低求助积分说明 812060